SOME EFFECTS OF CALCIUM ON ACTIVATION OF HUMAN FACTOR-8-VONWILLEBRAND-FACTOR PROTEIN BY THROMBIN

[1] PROPERTIES OF THROMBIN AND FIBRINOGEN - COMPARISON OF CLOTTING TIME AVERAGES [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1968, 20 (3-4): : 477 - &

[2] IMPORTANCE OF PROTEASE INHIBITION IN STUDIES ON PURIFIED FACTOR-VIII (ANTIHAEMOPHILIC FACTOR) [J]. THROMBOSIS AND HAEMOSTASIS, 1976, 35 (01) : 186 - 190

[3] STUDIES ON NATURE OF ANTIHEMOPHILIC FACTOR (FACTOR-VIII) - FURTHER EVIDENCE RELATING AHF-LIKE ANTIGENS IN NORMAL AND HEMOPHILIC PLASMAS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (09) : 2191 - 2197

[4] BLOMBACK M, 1974, THROMB RES, V5, P621, DOI 10.1016/0049-3848(74)90052-8

[5] IMMUNOLOGICAL CHARACTERIZATION OF PURIFIED ANTI-HEMOPHILIC FACTOR A (FACTOR-VIII) WHICH CORRECTS ABNORMAL PLATELET RETENTION IN VON WILLEBRANDS DISEASE [J]. NATURE-NEW BIOLOGY, 1972, 236 (65): : 104 - +

[6] EFFECTS OF THROMBIN TREATMENT ON PREPARATIONS OF FACTOR-8 AND CA2+-DISSOCIATED SMALL ACTIVE FRAGMENT [J]. JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (03) : 751 - 760

[7] FACTOR-VIII RECOMBINATION AFTER DISSOCIATION BY CACL2 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (08) : 2326 - 2329

[8] DEFECT IN HEMOPHILIC AND WILLEBRANDS DISEASE PLASMAS STUDIED BY A RECOMBINATION TECHNIQUE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (05) : 1093 - 1099

[9] PLASMA AGGREGATING FACTOR (BOVINE) FOR HUMAN PLATELETS - MARKER FOR STUDY OF ANTIHEMOPHILIC AND VON WILLEBRAND FACTORS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (10) : 2814 - 2818

[10] HERSHGOL.E, 1967, FED PROC, V26, P488

[1] PROPERTIES OF THROMBIN AND FIBRINOGEN - COMPARISON OF CLOTTING TIME AVERAGES [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1968, 20 (3-4): : 477 - &

[2] IMPORTANCE OF PROTEASE INHIBITION IN STUDIES ON PURIFIED FACTOR-VIII (ANTIHAEMOPHILIC FACTOR) [J]. THROMBOSIS AND HAEMOSTASIS, 1976, 35 (01) : 186 - 190

[3] STUDIES ON NATURE OF ANTIHEMOPHILIC FACTOR (FACTOR-VIII) - FURTHER EVIDENCE RELATING AHF-LIKE ANTIGENS IN NORMAL AND HEMOPHILIC PLASMAS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (09) : 2191 - 2197

[4] BLOMBACK M, 1974, THROMB RES, V5, P621, DOI 10.1016/0049-3848(74)90052-8

[5] IMMUNOLOGICAL CHARACTERIZATION OF PURIFIED ANTI-HEMOPHILIC FACTOR A (FACTOR-VIII) WHICH CORRECTS ABNORMAL PLATELET RETENTION IN VON WILLEBRANDS DISEASE [J]. NATURE-NEW BIOLOGY, 1972, 236 (65): : 104 - +

[6] EFFECTS OF THROMBIN TREATMENT ON PREPARATIONS OF FACTOR-8 AND CA2+-DISSOCIATED SMALL ACTIVE FRAGMENT [J]. JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (03) : 751 - 760

[7] FACTOR-VIII RECOMBINATION AFTER DISSOCIATION BY CACL2 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (08) : 2326 - 2329

[8] DEFECT IN HEMOPHILIC AND WILLEBRANDS DISEASE PLASMAS STUDIED BY A RECOMBINATION TECHNIQUE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (05) : 1093 - 1099

[9] PLASMA AGGREGATING FACTOR (BOVINE) FOR HUMAN PLATELETS - MARKER FOR STUDY OF ANTIHEMOPHILIC AND VON WILLEBRAND FACTORS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (10) : 2814 - 2818

[10] HERSHGOL.E, 1967, FED PROC, V26, P488